Moderna Announces EMA’s Committee for Medicinal Products for Human Use Recommends Booster Dose of Moderna’s COVID-19 Vaccine in the European Union
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for...
Ubiquigent Extends and Expands Drug Discovery Collaboration With Bristol Myers Squibb
Ubiquigent Limited announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide...
Aptar Pharma and i2c Pharmaceutical Services Announce Partnership for Next Generation Propellant Dispersible Tablet pMDI Technology
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, and i2c Pharmaceutical Services, a leading service provider for...
Vetter’s Contribution to Climate Protection: Corporate Sites Around the World are CO2-Neutral
The “Green Deal” initiated by the European Commission aims at reducing the net emissions of greenhouse gases to zero across the EU by 2050,...
BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the BD SCF™ PremiumCoat®† Plunger Stopper in partnership with...
Enzolytics and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies
Samsung Biologics , a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to...
Takara Bio Europe announces launch of CE-IVD registered RT-qPCR diagnostic kit for SARS-CoV-2
Takara Bio Europe (TBE) announced the launch of an in vitro diagnostic assay for the qualitative detection of novel coronavirus (SARS-CoV-2) from patients suspected...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...


























